Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Swedish Orphan Biovitrum AB (publ)
Cash from Financing Activities
Swedish Orphan Biovitrum AB (publ)
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
|
Cash from Financing Activities
kr15B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
20%
|
CAGR 10-Years
88%
|
|
Biogaia AB
STO:BIOG B
|
Cash from Financing Activities
-kr308.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
Hansa Biopharma AB
STO:HNSA
|
Cash from Financing Activities
-kr7.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Bonesupport Holding AB
STO:BONEX
|
Cash from Financing Activities
-kr6.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vitrolife AB
STO:VITR
|
Cash from Financing Activities
-kr300m
|
CAGR 3-Years
-125%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
-19%
|
|
BioArctic AB
STO:BIOA B
|
Cash from Financing Activities
kr14.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Swedish Orphan Biovitrum AB (publ)'s Cash from Financing Activities?
Cash from Financing Activities
15B
SEK
Based on the financial report for Mar 31, 2024, Swedish Orphan Biovitrum AB (publ)'s Cash from Financing Activities amounts to 15B SEK.
What is Swedish Orphan Biovitrum AB (publ)'s Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
88%